BNP Paribas Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.8M | Sell |
|
|||||
|
2025
Q1 | $30.1M | Buy |
|
|||||
|
2024
Q4 | $31M | Buy |
|
|||||
|
2024
Q3 | $40.3M | Sell |
|
|||||
|
2024
Q2 | $39.3M | Sell |
|
|||||
|
2024
Q1 | $32.4M | Buy |
|
|||||
|
2023
Q4 | $23.3M | Buy |
|
|||||
|
2023
Q3 | $24.8M | Buy |
|
|||||
|
2023
Q2 | $26.3M | Sell |
|
|||||
|
2023
Q1 | $23.6M | Buy |
|
|||||
|
2022
Q4 | $28.5M | Buy |
|
|||||
|
2022
Q3 | $26.2M | Buy |
|
|||||
|
2022
Q2 | $19.8M | Sell |
|
|||||
|
2022
Q1 | $27.9M | Buy |
|
|||||
|
2021
Q4 | $28.3M | Buy |
|
|||||
|
2021
Q3 | $36.9M | Sell |
|
|||||
|
2021
Q2 | $44.4M | Buy |
|
|||||
|
2021
Q1 | $40.9M | Buy |
|
|||||
|
2020
Q4 | $31M | Buy |
|
|||||
|
2020
Q3 | $14.4M | Buy |
|
|||||
|
2020
Q2 | $18.7M | Sell |
|
|||||
|
2020
Q1 | $14.9M | Sell |
|
|||||
|
2019
Q4 | $22M | Buy |
|
|||||
|
2019
Q3 | $11.5M | Buy |
|
|||||
|
2019
Q2 | $15.7M | Buy |
|
|||||
|
2019
Q1 | $19M | Buy |
|
|||||
|
2018
Q4 | $8.64M | Sell |
|
|||||
|
2018
Q3 | $19.3M | Buy |
|
|||||
|
2018
Q2 | $17M | Buy |
|
|||||
|
2018
Q1 | $13.7M | Sell |
|
|||||
|
2017
Q4 | $14.4M | Sell |
|
|||||
|
2017
Q3 | $17.1M | Buy |
|
|||||
|
2017
Q2 | $10.6M | Buy |
|
|||||
|
2017
Q1 | $9.34M | Buy |
|
|||||
|
2016
Q4 | $5.51M | Buy |
|
|||||
|
2016
Q3 | $5.37M | Buy |
|